Medicine and Dentistry
Bacterial Infection
100%
Neonates
96%
Diseases
77%
Asthma Exacerbation
64%
Clinical Immunology
64%
Wheeze
64%
Bacterium Lysate
64%
Antibiotics
62%
Pediatrics
54%
Sepsis
38%
Respiratory Tract Infection
37%
Severe Acute Respiratory Syndrome Coronavirus 2
35%
Pathogen
35%
Observational Study
34%
Meta-Analysis
32%
Systematic Review
32%
Noninferiority Trial
32%
Personalized Medicine
32%
Pediatrics Patient
32%
Serositis
32%
Emergency Department
32%
Seroprevalence
32%
Triage
32%
Immunology
32%
Polymerase Chain Reaction
32%
Prospective Cohort Study
32%
Blood Culture
32%
Sudden Unexpected Death in Epilepsy
32%
Post-COVID-19
32%
Group A Streptococcal Infection
32%
Prematurity
32%
Cost-Effectiveness Analysis
32%
Randomized Controlled Trial
32%
Lung
30%
Infection
26%
Virus
25%
Premature Labor
24%
Antibiotic Therapy
23%
Microbiome
21%
Placebo
21%
Virus Infection
20%
Asthma
16%
Lung Development
16%
Cell Activation
16%
COVID-19
15%
Newborn Period
14%
Escherichia coli
13%
Streptococcus Agalactiae
12%
Deterioration
11%
Intention-to-Treat Analysis
10%
Immunology and Microbiology
Asthma Exacerbation
64%
Clinical Immunology
64%
Newborn Period
48%
Severe Acute Respiratory Syndrome Coronavirus 2
43%
Bacterium Lysate
43%
COVID-19
36%
Cytotoxic T-Cell
32%
Influenza
32%
Immunology
32%
Viral Disease
32%
Dynamics
32%
Interleukin 33
32%
Seroprevalence
32%
Cytokine
32%
Pharmacokinetics
32%
Immune Response
32%
Asthma
32%
Solution and Solubility
32%
Immune System
32%
Polymerase Chain Reaction
32%
Lung Development
32%
Microbiome
32%
Prevalence
24%
Severe Asthma
21%
Maturation
21%
Survival Rate
16%
Streptococcus Agalactiae
12%
Blood Plasma
12%
Infectious Agent
11%
Immunosuppressive Drug
10%
Cytokine Storm
10%
Mouse Model
10%
CD4
10%
Innate Lymphoid Cell
10%
Dendritic Cell
10%
Cytokine Production
10%
CD8
10%
T Helper 2 Cell
10%
Intravenous Immunoglobulin
10%
Allergic Asthma
10%
Anticipation
10%
Allergic Airway Inflammation
10%
Disease Burden
10%
Microflora
10%
Monoclonal Antibody
10%
Infancy
10%
Immunomodulation
10%
Airway
10%
Virus
10%
Cell Maturation
10%
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacokinetics
96%
Antibiotics
73%
Diseases
72%
Bacterial Infection
71%
Clavulanic Acid
69%
Virus Infection
52%
Amoxicillin
49%
Prematurity
38%
Asthma
36%
Infectious Agent
35%
Chronic Obstructive Lung Disease
32%
Observational Study
32%
Noninferiority Trial
32%
Antimicrobial Therapy
32%
Neurologic Disease
32%
Beta Lactamase
32%
Sepsis
32%
Bacterium Lysate
32%
Premature Labor
24%
Antibiotic Therapy
24%
Reinfection
13%
Deterioration
12%
Prevalence
11%
Adverse Event
9%
Respiratory Virus
8%
Infection
8%
Microflora
8%
Chronic Disease
8%
Survival Rate
8%
Escherichia coli
7%
Bioavailability
6%
Viral Respiratory Tract Infection
6%
